finance the ACT-Accelerator in full and deploy adequate funding to ensure fair and equitable access to COVID-medicine, and diagnostics globally; 2. commit to work with the Access to Medicine Foundation and engage healthcare companies to promote corporate actions enabling the work of the ACT-Accelerator (e.g., cross-industry partnerships to accelerate research and development and expand production, equitable pricing strategies, and voluntary licensing agreements); and 3.